BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 15386352)

  • 41. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
    Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
    Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.
    Comerci JT; Runowicz CD; Flanders KC; De Victoria C; Fields AL; Kadish AS; Goldberg GL
    Cancer; 1996 Mar; 77(6):1107-14. PubMed ID: 8635131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
    Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
    Fujii T; Obara T; Tanno S; Ura H; Kohgo Y
    Hepatogastroenterology; 1999; 46(28):2299-308. PubMed ID: 10521987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
    Hasegawa Y; Takanashi S; Kanehira Y; Tsushima T; Imai T; Okumura K
    Cancer; 2001 Mar; 91(5):964-71. PubMed ID: 11251948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
    von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
    Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
    Foekens JA; Peters HA; Look MP; Portengen H; Schmitt M; Kramer MD; Brünner N; Jänicke F; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten WL; Klijn JG
    Cancer Res; 2000 Feb; 60(3):636-43. PubMed ID: 10676647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of invasion is of prognostic value in surgically treated cervical cancer patients.
    Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B; Richter CE; Braumann UD; Einenkel J
    Gynecol Oncol; 2006 Dec; 103(3):906-11. PubMed ID: 16876852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic relevance of fascin expression in human gastric carcinoma.
    Hashimoto Y; Shimada Y; Kawamura J; Yamasaki S; Imamura M
    Oncology; 2004; 67(3-4):262-70. PubMed ID: 15557788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
    Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
    BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transforming growth factor-β pathway activity in glioblastoma.
    Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
    Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wnt5A expression is associated with the tumor metastasis and clinical survival in cervical cancer.
    Lin L; Liu Y; Zhao W; Sun B; Chen Q
    Int J Clin Exp Pathol; 2014; 7(9):6072-8. PubMed ID: 25337253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
    Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Kojima S; Yamashita A; Tomio K; Nagamatsu T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
    Int J Oncol; 2016 Feb; 48(2):829-35. PubMed ID: 26676222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma.
    Yao Q; Du J; Lin J; Luo Y; Wang Y; Liu Y; Zhang B; Ren C; Liu C
    J Clin Pathol; 2016 Feb; 69(2):122-7. PubMed ID: 26254281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
    Zhang W; Hou T; Niu C; Song L; Zhang Y
    PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.